Drive Better Decisions &
Remain Compliant in the Field
In an effort to mitigate risk, many life sciences companies restrict the notes field reps may use to capture their interactions with HCPs. But this stance against using “free text” notes limits capturing the insights your field team needs for better decision-making.
In this interview, compliance expert Michael Shaw reviews how taking a progressive approach to field rep monitoring allows reps to capture more strategic and actionable data while still effectively mitigating risk.
You will learn:
Michael Shaw also shares his vision for advancing monitoring capabilities in the future.
About Michael Shaw
Michael Shaw is a results-driven leader with a proven track record of leading compliance programs and major organization transformations. Michael is currently the Global Head of Risk & Compliance at ZS Associates, where he is helping clients unlock a new level of innovation, performance, and patient outcomes by better navigating risk. Michael has over 25 years of experience in the pharma industry, including roles as Vice President of Ethics and Compliance at GSK and Global Head of Ethics and Compliance at Novartis Oncology. Prior to entering the pharma industry, Michael was a Director in PricewaterhouseCoopersʼ Global Pharma and Health Sciences Practice and was Senior Counsel with the Office of Inspector General of U.S. Department of Health and Human Services.
“Frankly, I get excited by the business insights that come with free text… I think it’s bringing insights to the business in some kind of real-time fashion so business leaders can take action on trends, whether that’s business trends or compliance risk."
President, Shaw Advisory Services
Share: